ecto5nucleotidase

Ecto-5'-nucleotidase, also known as CD73, is an enzyme encoded by the NT5E gene in humans. It is a glycosylphosphatidylinositol (GPI)-anchored protein found on the surface of various cells, including endothelial cells, lymphocytes, and fibroblasts. The enzyme plays a crucial role in purinergic signaling by catalyzing the hydrolysis of extracellular nucleotides. Specifically, it converts adenosine monophosphate (AMP) to adenosine, and adenosine diphosphate (ADP) to adenosine monophosphate (AMP). Adenosine is a potent neuromodulator and signaling molecule with diverse physiological effects.

The activity of ecto-5'-nucleotidase is important in regulating inflammatory responses, immune cell function, and vascular homeostasis. Adenosine, produced by CD73, can bind to adenosine receptors on target cells, leading to immunosuppressive and anti-inflammatory effects. This makes CD73 a significant target in research related to cancer immunology and autoimmune diseases. In cancer, CD73 expression on tumor cells and tumor-infiltrating immune cells can promote tumor growth and metastasis by creating an immunosuppressive tumor microenvironment, hindering anti-tumor immune responses. Conversely, in certain inflammatory conditions, its activity might be beneficial by dampening excessive immune activation. Its involvement in these complex biological processes highlights its importance in cellular communication and disease pathogenesis.